Related Experiment Video
Updated: Nov 22, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Molecular Characteristics of N1-Methyladenosine Regulators and Their Correlation with Overall Cancer Survival
Juan Li1,2, Chunting Zhang1,2, Xin Yuan1,2
1Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Abstract:
N1-methyladenosine (m1A) is a prevalent RNA modification widely affecting RNA structural stability, folding, and interactions with proteins. Recently, there have been increasing reports on the roles of m1A regulators in tumors. However, their mechanisms and clinical relevance remain unclear. This study systematically evaluates the epigenetic characteristics and clinical relevance of m1A regulators using bioinformatic methods. Our results show widespread gene expression changes for m1A regulators, which are related to the activation and inhibition of carcinogenic pathways and overall patient survival. Collectively, this investigation provides new insights into assessing tumor prognosis and targeted therapy.
Insights
N1-methyladenosine (m1A) regulators impact cancer by altering gene expression and patient survival. This study reveals their epigenetic roles, offering insights for tumor prognosis and targeted therapies.
Area of Science:
- Molecular Biology
- Epigenetics
- Oncology
Background:
- N1-methyladenosine (m1A) is a key RNA modification influencing RNA structure, stability, and protein interactions.
- Emerging evidence suggests m1A regulators play significant roles in tumorigenesis, but their precise mechanisms and clinical implications are not fully understood.
Purpose of the Study:
- To systematically investigate the epigenetic characteristics of m1A regulators.
- To evaluate the clinical relevance and prognostic value of m1A regulators in cancer.
Main Methods:
- Bioinformatic analysis was employed to assess gene expression patterns.
- Correlation between m1A regulator expression and carcinogenic pathways was examined.
- Impact on overall patient survival was analyzed.
Main Results:
- Significant alterations in m1A regulator gene expression were observed across various cancers.
- These expression changes were linked to the modulation of key carcinogenic pathways.
- m1A regulator expression levels were found to be significantly associated with patient survival outcomes.
Conclusions:
- m1A regulators exhibit widespread epigenetic alterations in tumors.
- These regulators are implicated in cancer development and progression through pathway modulation.
- m1A regulators represent potential biomarkers for tumor prognosis and novel targets for cancer therapy.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
MicroRNAs
RNA Stability
mTOR Signaling and Cancer Progression
The mTOR pathway or the...